Volume 37, Issue 2, Pages 172-175 (August 2002) Abelev GI, Assecritova IG, Kraevsky NA, Perova SD, Perevodchikova NI. Embryonal serum α-globulin in cancer patients. Diagnostic value [Int J Cancer 1967;2:551–558] Michael C Kew Journal of Hepatology Volume 37, Issue 2, Pages 172-175 (August 2002) DOI: 10.1016/S0168-8278(02)00163-0
Fig. 1 Test-system for the determination of αf-globulin: (1) absorbed antiserum (centre well); and (2) α-globulin fraction of foetal serum (reservoirs at 12 and 6 o'clock positions) in optimal dilution. (a) In well (3) αf-globulin-positive serum from patient. In well (5) αf-globulin-negative serum from patient. In wells (4) and (6) saline. (b) In wells (3–6) patient's serum diluted from 1/128 to 1/1024 (two-fold dilutions). (Reprinted with permission from John Wiley and Sons, Inc. [Int J Cancer 1967;2:551–558]). Journal of Hepatology 2002 37, 172-175DOI: (10.1016/S0168-8278(02)00163-0)
Fig. 2 Immunoelectrophoresis of a patient's serum and of a pooled serum from 50 healthy donors developed with antiserum against newborn blood serum (1); and against the same antiserum absorbed with the pool of sera from 50 donors (2). The horizontal line between (1) and (2) results from a reaction between antigen in absorbed serum and unabsorbed serum. αf: αf-globulin; P: patient's sera; and D: pool of sera from 50 donors. (Reprinted with permission from John Wiley and Sons, Inc. [Int J Cancer 1967;2:551–558]). Journal of Hepatology 2002 37, 172-175DOI: (10.1016/S0168-8278(02)00163-0)